Treatment With Pyrotinib–Based Therapy in Lapatinib–Resistant HER2-Positive MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study
Ther Adv Med Oncol 2022 Apr 01;14(2022)17588359221085232, Y Hua, W Li, N Jin, D Cai, J Sun, C Sun, F Yang, X Wu, X Huang, B Wang, Y YinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.